Clinical Trials Sponsored by Knop Laboratorios

Total 2093 results

Advenchen Laboratories Nanjing Ltd.

Recruiting

A Study of Diet Influence of AL8326 in Chinese Healthy Adult Subjects

Pharmacokinetics | Diet, High-Fat

China
Ache Laboratorios Farmaceuticos S.A.

Completed

Effectiveness Study of Ketoconazole and Betamethasone to Treat Fungal Infection and Dermatophytosis (DaVinci)

Tinea

Brazil
Ache Laboratorios Farmaceuticos S.A.

Withdrawn

Cefaliv® Compared to Neosaldina® in the Treatment of Migraine Attacks

Migraine Headache

Brazil
Ache Laboratorios Farmaceuticos S.A.

Withdrawn

Study to Evaluate the Efficacy and Safety of Fixed Dose Combination of Diphenhydramine + Pseudoephedrine + Dropropizine in the Control of Cough and the Relief of Nasal Symptoms, Suffering From Non-productive Cough and Acute Rhinitis

Cough | Nasal Congestion
Ache Laboratorios Farmaceuticos S.A.

Completed

Efficacy and Safety of Levetiracetam in Partial Seizures Control, With or Without Secondary Generalization (Mozart)

Epilepsy | Partial Seizures
Ache Laboratorios Farmaceuticos S.A.

Withdrawn

Efficacy and Safety of a Fixed-dose Combination of Naratriptan and Naproxen in Acute Treatment of Migraine (Atenéia)

Migraine | Headache
Ache Laboratorios Farmaceuticos S.A.

Withdrawn

Study Comparing 3 Formulations to Evaluate the Efficacy and Safety of the Inflammatory Symptoms of the Upper Respiratory Tract, in Children Between 2 and 6 Years Old

Common Cold

Brazil
Ache Laboratorios Farmaceuticos S.A.

Withdrawn

Efficacy and Safety of ACH24 in the Treatment of Vitiligo

Vitiligo

Brazil
Ache Laboratorios Farmaceuticos S.A.

Completed

Efficacy and Safety of Glucosamine Sulfate and Chondroitin Sulfate Combination in Treatment of Knee Osteoarthritis

Knee Osteoarthritis

Brazil
Ranbaxy Laboratories Limited
Ohm Laboratories, Inc.

Completed

Bioequivalence Study of Cetirizine Hydrochloride 10mg Tablets Under Fed Conditions

Healthy

United States
Filip Krag Knop
Juvenile Diabetes Research Foundation; University of Copenhagen

Recruiting

Repurposing Colchicine for Reduction of Residual Inflammatory Risk in Type 1 Diabetes (REC1TE)

Cardiovascular Diseases | Type 1 Diabetes | Chronic Inflammation

Denmark
Dermal Laboratories Ltd

Not yet recruiting

A Study to Evaluate the Emollient Performance of Doublebase Once in the Treatment of Atopic Eczema

Atopic Eczema
Rovi Pharmaceuticals Laboratories

Recruiting

Pharmacokinetics, Safety and Tolerability of Different Formulations and Dose Strengths of Quarterly Risperidone (QUAR) in Patients With Schizophrenia (QUARTZ)

Schizophrenia

Jordan
Upsher-Smith Laboratories

Recruiting

Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old

Migraine Disorders

United States
Dermal Laboratories Ltd

Completed

A Study to Evaluate Adex Gel in the Treatment of Atopic Eczema.

Atopic Eczema

United Kingdom
Wren Laboratories LLC

Enrolling by invitation

RegisterNET - A Registry for Neuroendocrine Tumors in the USA (RegisterNET)

Neuroendocrine Tumor | Neuroendocrine Carcinoma | Carcinoid

United States
Rovi Pharmaceuticals Laboratories

Active, not recruiting

Evaluation of IM Letrozole ISM® Pharmacokinetics, Safety, and Tolerability in Healthy Post-menopausal Women (LISA-1)

Healthy

Czechia
Impax Laboratories, LLC

Completed

Open Label Extension (OLE) Study of the Safety and Clinical Utility of IPX203 in Parkinson's Disease (PD) Participants With Motor Fluctuations

Parkinson Disease

United States, Czechia, France, Germany, Italy, Poland, Spain, United Kingdom
Crown Laboratories, Inc.

Completed

A Study to Evaluate the Efficacy of Microneedling as a Stand-alone Treatment for Vitiligo

Vitiligo

United States
MedMira Laboratories Inc.

Withdrawn

Rapid Diagnostics for HIV and Hepatitis

HIV Infections | Hepatitis B Infections | Hepatitis C Infections

United States
Impax Laboratories, LLC

Completed

A Study to Evaluate the Safety and Efficacy of IPX203 in Parkinson's Disease Participants With Motor Fluctuations

Parkinson's Disease (Disorder)

United States, Czechia, France, Italy, Spain, Germany, Poland, United Kingdom
Advenchen Laboratories, LLC

Available

Catequentinib in Patients Who Have Completed an Advenchen Study (A Compassionate Use Trial)

Gynecologic Cancer | Sarcoma,Soft Tissue
Starkey Laboratories, Inc

Completed

Self Fitting Hearing Aid Clinical Investigation

Hearing Loss, Sensorineural

United States
Crown Laboratories, Inc.

Completed

A Proof of Concept Study to Evaluate the Efficacy and Tolerability of Microneedling With SkinPen in Female and Male Subjects With Facial Acne Vulgaris, Ages 18 Through 45

Acne Vulgaris

United States
Rovi Pharmaceuticals Laboratories

Completed

Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia: Open Label Extension (PRISMA-3_OLE)

Schizophrenia

United States, Ukraine
Rovi Pharmaceuticals Laboratories

Completed

Study to Evaluate the Efficacy and Safety of Risperidone in Situ Microparticle (ISM)® in Patients With Acute Schizophrenia (PRISMA-3)

Acute Schizophrenia

United States, Ukraine
Nova Laboratories Limited

Completed

Pharmacokinetics of Oral Hydroxyurea Solution (HUPK)

Sickle Cell Disease | Sickle Cell Hemoglobin C | Sickle Cell-beta-thalassemia | Sickle-Cell; Hemoglobin Disease, Thalassemia

United Kingdom, Jamaica
Diatherix Laboratories, LLC

Suspended

TEM-PCR™ Prospective Clinical Utility Study

Upper Resp Tract Infection

United States
Crown Laboratories, Inc.

Completed

A Six Week Topical Cream Study for Subjects With Ichthyosis Vulgaris

Ichthyosis Vulgaris

United States
Paradigm Laboratories LLC

Unknown

COVID-19 Tests With Saliva Specimens

Covid19

United States
Impax Laboratories, LLC

Completed

A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis

Multiple Sclerosis | Spasticity

United States
Impax Laboratories, LLC

Completed

IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis

Multiple Sclerosis

United States, Canada, Estonia, Latvia, Ukraine
Charleston Laboratories, Inc

Completed

A Study to Assess the Efficacy and Safety of Oral CL-H1T in the Treatment of Acute Migraine Pain

Pain | Nausea | Vomiting | Migraine | Aura

United States
Impax Laboratories, LLC

Completed

A Study to Compare IPX066 and Carbidopa/Levodopa/Entacapone (CLE) Followed by an Open-Label Safety Study of IPX066

Parkinson's Disease

Germany, United States, France, Italy
Impax Laboratories, LLC

Completed

Comparison of IPX054 and Immediate-Release Carbidopa-Levodopa in Patients With Parkinson's Disease

Parkinson's Disease

United States
Concordia Laboratories Inc.

Terminated

Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS)

Hilar Cholangiocarcinoma

United States, Korea, Republic of, Canada, Switzerland, Germany
Aponia Laboratories, Inc.

Completed

Phase II Study of AP0302 5% Versus a Vehicle Comparator

Pain | Delayed Onset Muscle Soreness

United States
Bühlmann Laboratories AG

Completed

IBDoc® Canadian User Performance Evaluation

Inflammatory Bowel Diseases

Canada
Pfizer
Forest Laboratories

Completed

A Study to Evaluate the Efficacy and Safety of Intravenous Ceftaroline Versus Intravenous Ceftriaxone in the Treatment of Adult Hospitalised Patients With Community-Acquired Bacterial Pneumonia in Asia

Community-Acquired Bacterial Pneumonia | Lung Infection of Individual Not Recently Hospitalized

Korea, Republic of, Vietnam, China, Taiwan, India
Pfizer
Forest Laboratories

Completed

Safety and Tolerability of Ceftazidime-Avibactam for Pediatric Patients With Suspected or Confirmed Infections

Systemic Infections

United States
Pfizer
Forest Laboratories

Completed

Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections

Complicated Skin and Soft Tissue Infection

United States, Croatia, Australia, Bulgaria, Italy, Korea, Republic of, Mexico, Peru, Poland, Russian Federation, South Africa, Spain, Turkey, Philippines, China, Romania, Argentina, Brazil, Chile, Czechia, Israel, Greece, Taiwan, Ukr... and more
Pfizer
Forest Laboratories

Completed

Ceftaroline China Pharmacokinetics Study (CeftarolineChi)

Healthy

China
Charleston Laboratories, Inc

Completed

A Four-Period, Four-Treatment, Four-Way Relative Bioavailability Study of CL-108 Under Fed and Fasted Conditions

Healthy
Impax Laboratories, LLC

Completed

Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)

Restless Legs Syndrome

United States
Charleston Laboratories, Inc

Completed

Phase III Study of the Safety and Efficacy of Cl-108 in the Treatment of Moderate to Severe Pain

Pain | Nausea | Vomiting

United States
Forest Laboratories
AstraZeneca

Completed

Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Community Acquired Bacterial Pneumonia (CABP)

Infections | Community Acquired Pneumonia

Spain, United States, Argentina, Bulgaria, Georgia, Greece, Hungary, Poland, Ukraine
Romark Laboratories L.C.

Completed

Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin for the Treatment of Hepatitis C (STEALTHC-2)

Chronic Hepatitis C

United States
Paddock Laboratories, Inc.

Completed

A Study to Compare the Relative Bioavailability of Moexipril HCl/Hydrochlorothiazide in Healthy Adult Volunteers Under Fasting Conditions

Healthy

United States
Fresh Medical Laboratories

Completed

Evaluate the Utility of the ProLung Test as Adjunctive to CT Scan in the Diagnosis of Lung Cancer

Multiple Pulmonary Nodules | Solitary Pulmonary Nodule

United States
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 50 mg

Fasting

India

3

Subscribe